Session Information
2012 Midyear Clinical Meeting
Click here to go to the previous page
Advanced Topics: Treating Your Patient with Novel Oral Anticoagulants
Track: Education Sessions (CE)
Program Code: 241-L01
Date: Thursday, December 6, 2012
Time: 2:00 PM to 4:00 PM EST
Location: Mandalay Bay J, Level 2, South Convention Center
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 Edith Nutescu, PharmD, FCCP, Clinical Professor, University of Illinois at Chicago, College of Pharmacy
 Maureen Smythe, PharmD, FCCP, Professor (Clinical), Pharmacy Practice, Wayne State University
 Lynda Thomson, PharmD, CACP, Advance Practice Pharmacist, Anticoagulation, Thomas Jefferson University Hospital
PROGRAM CHAIR:   Click the plus sign to see more detailed information about each speaker.
 Maureen Smythe, PharmD, FCCP, Professor (Clinical), Pharmacy Practice, Wayne State University
Description
Patient Case, Maureen Smythe, PharmD, FCCP

Differentiating New Oral Anticoagulants for Stroke Prevention, Edith Nutescu, PharmD, FCC

Renal Impairment and Laboratory Monitoring: What Clinicians Should Know, Maureen A. Smythe, PharmD, FCCP

Optimizing Transitions of Care, Lynda J. Thomson, PharmD, FCCP

LEARNER OUTCOMES:
  • Compare and contrast dabigatran, rivaroxaban and apixaban therapy for stroke prevention in patients with atrial fibrillation.
  • Discuss approaches to and limitations of laboratory monitoring with newer agents.
  • Discuss strategies for peri procedural management with the newer agents.
  • Explain the impact of renal dysfunction of the safety and efficacy of the newer agents.
  • Outline considerations for transitions of care and patient education.


Audio Synchronized to PowerPoint
(Code: 241-L01)
Attendee:Free
  
This session is a part of: